Daiichi Sankyo Company, Limited (DSKYF)
OTCMKTS
· Delayed Price · Currency is USD
23.70
+0.15 (0.64%)
May 13, 2025, 3:08 PM EDT
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Healthcare (OTC) Products | 86.59B |
Log In |
Log In |
Log In |
Log In |
| Healthcare (OTC) Products Growth | 14.09% |
Log In |
Log In |
Log In |
Log In |
| Other | 2.69B |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 13.06% |
Log In |
Log In |
Log In |
Log In |
| Prescription Drugs | 1,796.97B |
Log In |
Log In |
Log In |
Log In |
| Prescription Drugs Growth | 17.96% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Japan Revenue | 583.80B |
Log In |
Log In |
Log In |
Log In |
| Japan Revenue Growth | -2.70% |
Log In |
Log In |
Log In |
Log In |
| Europe Revenue | 418.21B |
Log In |
Log In |
Log In |
Log In |
| Europe Revenue Growth | 34.54% |
Log In |
Log In |
Log In |
Log In |
| North America Revenue | - |
Log In |
Log In |
Log In |
Log In |
| North America Revenue Growth | - |
Log In |
Log In |
Log In |
Log In |
| Other Regions Revenue (Pre-FY2025 Reporting) M | - |
Log In |
Log In |
Log In |
Log In |
| Other Regions Revenue (Pre-FY2025 Reporting) M Growth | - |
Log In |
Log In |
Log In |
Log In |
| United States Revenue | 642.22B |
Log In |
Log In |
Log In |
Log In |
| United States Revenue Growth | 30.37% |
Log In |
Log In |
Log In |
Log In |
| Other Regions Revenue (Post-FY2024 Reporting) M | 242.03K |
Log In |
Log In |
Log In |
Log In |
| Other Regions Revenue (Post-FY2024 Reporting) M Growth | 22.08% |
Log In |
Log In |
Log In |
Log In |